Evidence grading for HIV indicator conditions
Evidence grading for HIV indicator conditions (where HIV test is recommended), defined by having an undiagnosed HIV prevalence of at least 1 per 1000 (from draft UK HIV Testing Guidelines 2026)
| Indicator condition |
Strength of recommendation (1/2) |
Grade of evidence (A–D) |
|
Community-acquired pneumonia (requiring hospital admission) |
1
|
B C for CAP where not admitted |
| Hepatitis A | 1 | B |
| Hepatitis B or C (acute or chronic) | 1 | B |
| Herpes zoster | 1 aged <60 | B |
| Lymphoma | 1 | B |
| Mononucleosis-like illness |
1 aged <60 2 aged >60 |
B |
| Oral hairy leukoplakia | 1 | B |
| Sexually transmitted infection | 1 | B |
|
Unexplained leukocytopenia/ thrombocytopenia lasting >4 weeks1 |
1 | B |
| Unexplained lymphadenopathy | 1 | B |
| Unexplained weight loss | 1 | C |
| Cervical dysplasia | 1 | C |
| Invasive pneumococcal disease | 1 | C |
| Seborrheic dermatitis/exanthema | 1 aged <60 | C |
| Unexplained oral/oesophageal candidiasis |
1 2 aged >60** |
C |
| Visceral leishmaniasis | 1 | C |
| Anal cancer/dysplasia | 2 | C |
| Unexplained chronic diarrhoea | 2 | C |
| Peripheral neuropathy | 2 | C |
| Mononeuritis | 2 | C |
| Primary lung cancer | 2 | D |
| Unexplained fever | 2 | C |
| Candidaemia | 2 | D |
| Guillain–Barré syndrome | 2 | C |
1Confirmed result outside local lab reference range.